News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement

Peter Gassner

Advertisement

Articles by Peter Gassner

As Change Continues, Are You Digitally Fit For the Future?

ByPeter Gassner
February 9th 2022

Digital disruption is poised to usher in a new era of customer-centricity and efficiency, starting with trials and precision targeting.

Digital Disruption is Coming: Are You Ready?

ByPeter Gassner
November 18th 2016

The steps to stay ahead of the looming shakeup in pharma.

Advertisement

Latest Updated Articles

  • Digital Disruption is Coming: Are You Ready?
    Digital Disruption is Coming: Are You Ready?

    November 18th 2016



Advertisement
Advertisement

Trending on PharmExec

1

Vinay Prasad Out at CBER for Second Time in Under a Year

2

Key Factors Contributing to Uncertainty in Moderna's mRNA Vaccine Review

3

Ipsen Withdraws Tazverik from Market Due to Emerging Data from Clinical Trial

4

Mergers and Acquisitions Roundup: GSK and Alfasigma Enter Licensing Agreement for Linerixibat, Servier Enters $2.5 Billion Definitive Agreement to Acquire Day One Pharmaceuticals

5

The Impact of a CRM Transition: Q&A with David Rosner

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us